Pay for performance and contractual choice: the case of general practitioners in England

from Health Economics Review at http://bit.ly/2js7SwZ on January 31, 2017 at 01:28PM The Quality and Outcomes Framework (QOF) is a Pay-for-Performance scheme introduced in England in 2004 to reward primary care providers. This incentive scheme provides financial incentives that reward the over…

The impact of resilience on psychological outcomes in women with threatened premature labor and spouses: a cross-sectional study in Southwest China

from Health and Quality of Life Outcomes at http://bit.ly/2jRIZqG on January 31, 2017 at 10:33AM Threatened premature labor (TPL) is a severe obstetric complication which affects the mental and physical health of both the mother and fetus. Family resilience may have protective role against psychological d…

Validation of the dutch version of the health education impact questionnaire (HEIQ) and comparison of the Dutch translation with the English, German and French HEIQ

from Health and Quality of Life Outcomes at http://bit.ly/2jRimUW on January 31, 2017 at 10:33AM The Health Education Impact Questionnaire (heiQ) evaluates the effectiveness of health education and self-management programs provided to people dealing with a wide range of conditions. Aim of this study was t…

The LMC Skills, Confidence & Preparedness Index (SCPI): development and evaluation of a novel tool for assessing self-management in patients with diabetes

from Health and Quality of Life Outcomes at http://bit.ly/2jRIVXY on January 31, 2017 at 10:33AM Optimal diabetes care requires a specific set of self-management behaviours. The purpose of this study was to present the development and initial psychometric evaluation of a new tool to measure three key aspe…

A “healthy immigrant effect” or a “sick immigrant effect”? Selection and policies matter

from The European Journal of Health Economics at http://bit.ly/2jQJvYj on January 31, 2017 at 07:33AM Abstract Previous literature on a variety of countries has documented a “healthy immigrant effect” (HIE). Accordingly, immigrants arriving in the host country are, on average, healthier than comparable natives. However, their health status dissipates with additional years in the country. […]

In search of sweet spots in public policy

from The Incidental Economist at http://bit.ly/2kKVSnc on January 31, 2017 at 05:00AM The following is a guest post by Keith Humphreys, a Professor of Psychiatry at Stanford University and Former White House Policy Advisor. Increasing government spending improves educational outcomes and doesn’t enhance them at all.  Augmenting incarceration rates reduces crime and increases it. Raising […]

CHE to participate in a new EU H2020 IMI2 funded project aiming to identify faster, more effective and cost-effective care for patients with haematological malignancies

from Centre for Health Economics – Latest news at http://bit.ly/2jyeqVR on January 31, 2017 at 03:32AM Patients struggling with blood disorders may look forward to more rapid and efficient treatment from the outcomes of the HARMONY project, an initiative that aims to create a roadmap for better access and care for patients with various blood […]

CHE to participate in a new EU H2020 IMI2 funded project aiming to identify faster, more effective and cost-effective care for patients with haematological malignancies

from Centre for Health Economics – Latest news at http://bit.ly/2jyeqVR on January 31, 2017 at 03:32AM Patients struggling with blood disorders may look forward to more rapid and efficient treatment from the outcomes of the HARMONY project, an initiative that aims to create a roadmap for better access and care for patients with various blood […]

Drug Pricing in South Korea

from Applied Health Economics and Health Policy at http://bit.ly/2kL3fye on January 30, 2017 at 11:21AM Abstract Between 2000 and 2013, spending on medicines in Korea increased by 275.3%. In order to curb this trend, several pricing policies and measures were introduced. This study reviews these policies and their implications based on pricing regulations as well […]

CEA in the USA

from Health Economics Group at http://bit.ly/2kLfYkv on January 30, 2017 at 11:08AM by Diarmuid Coughlan It’s a new dawn, it’s a new day in America. The Trump administration is now in power. From the get-go, the new President has been busy signing executive orders on his campaign pledges which included repealing the Affordable Care Act […]

The PROMIS fatigue item bank has good measurement properties in patients with fibromyalgia and severe fatigue

from Quality of Life Research at http://bit.ly/2kjTfuI on January 30, 2017 at 10:18AM Abstract Purpose Efficient management of fibromyalgia (FM) requires precise measurement of FM-specific symptoms. Our objective was to assess the measurement properties of the Patient-Reported Outcome Measurement Information System (PROMIS) fatigue item bank (FIB) in people with FM. Methods We applied classical psychometric […]

CCHE Seminar Series

from CCHE General Updates Archive Feed at http://bit.ly/2jmEDeF on January 30, 2017 at 07:31AM Canadian Centre for Health Economics View this email in your browser Dear All, As part of the Canadian Centre for Health Economics (CCHE) Friday Health Economics Series, we welcome Kaveh Katebian this Friday February 3rd, 10am – 12pm in HS100 (Health […]

Early Assessment of the Likely Cost Effectiveness of Single-Use Flexible Video Bronchoscopes

from PharmacoEconomics – Open at http://bit.ly/2jK8UTy on January 30, 2017 at 05:42AM Abstract Background Bronchoscopic procedures are common in the clinical setting, with estimates indicating 500,000 are undertaken per year in the USA alone. These procedures are generally regarded as safe. Unfortunately, a risk of cross-contamination between patients, with possible subsequent infection, is associated with […]

Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK

from PharmacoEconomics – Open at http://bit.ly/2jNfrdM on January 30, 2017 at 05:42AM Abstract Purpose Our objective was to estimate the economic outcomes of using mirabegron versus antimuscarinics in the treatment of patients with overactive bladder (OAB) from a societal perspective in the UK. Materials and Methods A Markov model was developed using Microsoft Excel®. The […]